vestarВестник аритмологииJournal of Arrhythmology1561-86412658-7327НАО «Инкарт»vestar-438Research ArticleОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯORIGINAL ARTICLESВЛИЯНИЕ ГЕНДЕРНЫХ ФАКТОРОВ НА ХАРАКТЕР АНТИТРОМБОТИЧЕСКОЙ ТЕРАПИИ У ПАЦИЕНТОВ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙGENDER EFFECT ON ANTITHROMBOTIC TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATIONНовиковаН. А.NovikovaN. A.noemail@neicon.ruСорокинаЕ. Г.SorokinaE. G.noemail@neicon.ruГиляровМ. Ю.GilyarovM. Yu.noemail@neicon.ruСаркисоваН. Д.SarkisovaN. D.noemail@neicon.ruГОУ ВПО Московская медицинская академия имени И.М.СеченоваRussian Federation2009220920200582125Copyright © Новикова Н.А., Сорокина Е.Г., Гиляров М.Ю., Саркисова Н.Д., 20202020Новикова Н.А., Сорокина Е.Г., Гиляров М.Ю., Саркисова Н.Д.Novikova N.A., Sorokina E.G., Gilyarov M.Y., Sarkisova N.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vestar.elpub.ru/jour/article/view/438

C целью изучения влияния гендерных факторов на характер и особенности проводимой антитромботической терапии обследовано 377 человек (213 женщин и 164 мужчины) с постоянной, персистирующей или пароксизмальной формой фибрилляции предсердий в возрасте от 27 до 89 лет (средний возраст 67,4±9,53 лет).

To study the gender effect on the peculiar features of antithrombotic therapy, 377 patients (213 women and 164 men) with chronic, persistent, or paroxysmal atrial fibrillation aged 27 89 years (mean 67.4±9.53 years) were examined.

фибрилляция предсердийтромбоэмболические осложненияшкала CHADS2антитромботическая терапияварфаринаспиринмеждународное нормализованное отношениеatrial fibrillationthromboembolismCHADS2 scaleantithrombotic therapyWarfarinAspirininternational normalized ratioReferencesFuster V., Rydén L.E., Cannom D.S., et al. ACC/AHA/ ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines.// Circulation, 2006; 114:257-354Fuster V., Rydén L.E., Cannom D.S., et al. ACC/AHA/ ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines.// Circulation, 2006; 114:257-354Friberg J., Scharling H., Gadsboll N., et al. Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study).// American Journal of Cardiology, 2003; 92(12):1419-1423Friberg J., Scharling H., Gadsboll N., et al. Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study).// American Journal of Cardiology, 2003; 92(12):1419-1423Olshansky B., Rosenfeld L., Warner A., et al. The AFFIRM Study: Approaches to control rate in atrial fibrillation.// J. Am. Coll. Cardiol., 2004; 43:1201-1208Olshansky B., Rosenfeld L., Warner A., et al. The AFFIRM Study: Approaches to control rate in atrial fibrillation.// J. Am. Coll. Cardiol., 2004; 43:1201-1208Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.// Stroke, 1991; 22:983-988Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.// Stroke, 1991; 22:983-988Hart R., Halperin J.L. Atrial fibrillation and stroke. Concepts and controversies// Stroke, 2001; 32:803-808Hart R., Halperin J.L. Atrial fibrillation and stroke. Concepts and controversies// Stroke, 2001; 32:803-808Friberg J., Scharling H., Gadsboll N. et al. Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). American Journal of Cardiology, 2003; 92(12):1419-1423Friberg J., Scharling H., Gadsboll N. et al. Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). American Journal of Cardiology, 2003; 92(12):1419-1423Fang M.C. Singer D.E., Chang Y., Hylek E.M., et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.// Circulation, 2005; 112(12):1687-91Fang M.C. Singer D.E., Chang Y., Hylek E.M., et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.// Circulation, 2005; 112(12):1687-91Dagres N., Nieuwlaat R., Vardas P., et al. Gender-related differences in presentation, treatment, and outcomes of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on atrial fibrillation.// J. Am. Coll. Cardiol., 2007; 49(5):572-577Dagres N., Nieuwlaat R., Vardas P., et al. Gender-related differences in presentation, treatment, and outcomes of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on atrial fibrillation.// J. Am. Coll. Cardiol., 2007; 49(5):572-577Hart R.G., Pearce L.A., Aguilar M.I. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.// Ann. Intern. Med., 2007; 146:857-867Hart R.G., Pearce L.A., Aguilar M.I. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.// Ann. Intern. Med., 2007; 146:857-867Carlsson J. Mortality and stroke rates in a trial of Rhythm Control versus Rate Control in atrial fibrillation: results from the STAF Pilot Phase (Strategies of Treatment of Atrial Fibrillation).// J. Amer. Coll. Cardiol., 2001; 38(3):603-604Carlsson J. Mortality and stroke rates in a trial of Rhythm Control versus Rate Control in atrial fibrillation: results from the STAF Pilot Phase (Strategies of Treatment of Atrial Fibrillation).// J. Amer. Coll. Cardiol., 2001; 38(3):603-604Lip G., Watson T., Shantsila E. Anticoagulation for stroke prevention in atrial fibrillation: is gender important?// European Heart Journal, 2006; 27(16):1893-1894Lip G., Watson T., Shantsila E. Anticoagulation for stroke prevention in atrial fibrillation: is gender important?// European Heart Journal, 2006; 27(16):1893-1894Hylek E., Go A., Chang Y., et al. Effect of intensity of oral anticoagulation on stroke severity and morality in atrial fibrillation// N. Engl. J. Med., 2003; 349:1019-26Hylek E., Go A., Chang Y., et al. Effect of intensity of oral anticoagulation on stroke severity and morality in atrial fibrillation// N. Engl. J. Med., 2003; 349:1019-26

The authors declare that there are no conflicts of interest present.